Plasma genetic and genomic abnormalities predict treatment response and clinical outcome in advanced prostate cancer

Liquid biopsies, examinations of tumor components in body fluids, have shown promise for predicting clinical outcomes. To evaluate tumor-associated genomic and genetic variations in plasma cell-free DNA (cfDNA) and their associations with treatment response and overall survival, we applied whole gen...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Shu, Kohli, Manish, Du, Meijun, Dittmar, Rachel L., Lee, Adam, Nandy, Debashis, Yuan, Tiezheng, Guo, Yongchen, Wang, Yuan, Tschannen, Michael R., Worthey, Elizabeth, Jacob, Howard, See, William, Kilari, Deepak, Wang, Xuexia, Hovey, Raymond L., Huang, Chiang-Ching, Wang, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599278/
https://www.ncbi.nlm.nih.gov/pubmed/25915538

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599278/
https://www.ncbi.nlm.nih.gov/pubmed/25915538

Ejemplares similares